Cantor Fitzgerald initiated coverage on Korro Bio with a new price target
$KRRO
Biotechnology: Pharmaceutical Preparations
Health Care
Cantor Fitzgerald initiated coverage of Korro Bio with a rating of Overweight and set a new price target of $74.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/29/2025 | $74.00 | Overweight | Cantor Fitzgerald |
| 4/16/2025 | $25.00 | Buy | Chardan Capital Markets |
| 1/10/2025 | $155.00 | Outperform | Oppenheimer |
| 10/21/2024 | $153.00 | Strong Buy | Raymond James |
| 8/14/2024 | $180.00 | Outperform | William Blair |
| 3/28/2024 | $100.00 → $115.00 | Buy | H.C. Wainwright |
| 2/27/2024 | $120.00 | Outperform | BMO Capital Markets |
| 12/4/2023 | $100.00 | Buy | H.C. Wainwright |